The Latest Cardiac and Vascular News
CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2020. Recent Highlights: Reported revenue of $3.2 million in the third quarter ended September 30, 2020, a 180% increase […]
Breakthrough Technology, Combined with Acutus Non-Contact Mapping May Enable Rapid, Safe and Effective Arrhythmia Treatment CARLSBAD, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (NASDAQ:AFIB) today announced pre-clinical experimental results of a novel diagnostic and therapeutic workflow utilizing the AcQMap® System along with tissue-selective, non-thermal pulse field ablation (PFA) via a proprietary Acutus ablation catheter. […]
ST. LOUIS and CARLSBAD, Calif., July 31, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS) and Acutus Medical today announced the first integrated cardiac ablation procedure benefiting from remote TeleRobotic Support. Dr. Gery Tomassoni of Baptist Health in Lexington, KY treated the patient utilizing integrated Stereotaxis Robotic Magnetic Navigation and Acutus AcQMap systems supported by technical and clinical experts from […]
CARLSBAD, Calif., July 11, 2019 /PRNewswire/ — Acutus Medical today announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The study demonstrated 73 percent single-procedure freedom from atrial fibrillation (AF) at 12 months with the use of Acutus’ AcQMap advanced cardiac imaging and mapping system. Acutus develops next-generation electrophysiology (EP) technology solutions built into an open […]
CARLSBAD, California, June 24, 2019 /PRNewswire/ — Acutus Medical today announced a $170 million financing, including a $100 million Series D equity financing and a $70 million credit facility. The funding is intended to accelerate commercialization and facilitate global business development activities as the company continues to transform arrhythmia care through distinct, innovative technologies designed to provide physicians and patients with improved results. The Series […]
